CCP
XRAY icon

Corient Capital Partners’s Dentsply Sirona XRAY Stock Holding History

Corient Capital Partners’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$286K Buy
7,998
+6
+0.1% +$205 0.02% 478
2022
Q2 		$286K Sell
7,992
-451
-5% -$18.2K 0.02% 490
2022
Q1 		$416K Buy
8,443
+218
+3% +$11.5K 0.03% 424
2021
Q4 		$459K Sell
8,225
-101
-1% -$5.55K 0.03% 389
2021
Q3 		$483K Sell
8,326
-169
-2% -$10.4K 0.04% 367
2021
Q2 		$537K Buy
8,495
+330
+4% +$21.7K 0.04% 341
2021
Q1 		$521K Buy
8,165
+460
+6% +$26.7K 0.04% 310
2020
Q4 		$404K Buy
7,705
+96
+1% +$4.74K 0.04% 315
2020
Q3 		$333K Sell
7,609
-149
-2% -$6.59K 0.04% 319
2020
Q2 		$342K Sell
7,758
-217
-3% -$9.18K 0.04% 306
2020
Q1 		$310K Sell
7,975
-1,037
-12% -$52.8K 0.05% 292
2019
Q4 		$510K Buy
9,012
+143
+2% +$7.97K 0.06% 276
2019
Q3 		$473K Buy
8,869
+173
+2% +$9.29K 0.07% 274
2019
Q2 		$507K Buy
8,696
+291
+3% +$15.6K 0.08% 235
2019
Q1 		$417K Buy
+8,405
New +$370K 0.07% 248

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Corient Capital Partners's XRAY Position: Q3 2022 in Review

Corient Capital Partners increased its Dentsply Sirona (XRAY) stake by 0.08% in Q3 2022, buying an estimated $205 and bringing the position to 7,998 shares worth $286K. The position accounts for 0.02% of the portfolio, ranked #478.

Corient Capital Partners first reported a position in XRAY in Q1 2019 and has held it in 15 quarters since. The position peaked at $537K in Q2 2021. 460 funds tracked by Wall St. Rank hold XRAY as of Q3 2022.

  • Corient Capital Partners held 7,998 shares of Dentsply Sirona worth $286K as of Q3 2022.
  • Corient Capital Partners bought 6 Dentsply Sirona shares in Q3 2022, an estimated $205.
  • Dentsply Sirona made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #478 holding.
  • Corient Capital Partners first reported a position in Dentsply Sirona in Q1 2019 and has held it in 15 quarters since.
  • Corient Capital Partners's Dentsply Sirona position peaked at $537K in Q2 2021.
  • 460 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.